Loading provider…
Loading provider…
Hematology & Oncology Physician in Scottsdale, AZ
NPI: 1326054115Primary Practice Location
MUSC MEDICAL CENTER
25 Courtenay Dr, Charleston, SC
Primary Employer
MUSC Physicians
muschealth.org
HQ Phone
Get M.D./PH.D. Thai's Phone Numberphone_androidMobile
Get M.D./PH.D. Thai's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
TX State Medical License
AZ State Medical License
AZ State Medical License
2012 - 2027
SC State Medical License
2023 - 2027
TX State Medical License
2009 - 2026
CA State Medical License
2012 - 2021

American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
2009 - 2012
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
2006 - 2009
Baylor College Of Medicine
bcm.edu
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 119 | 137 |
| 2 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 74 | 172 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 69 | 94 |
| 4 | J2405Injection, ondansetron hydrochloride, per 1 mg | 60 | 652 |
| 5 | J1100Injection, dexamethasone sodium phosphate, 1 mg | 45 | 508 |
The Immune Landscape of Cancer.
Authors: Mary Disis, Jeffrey Hooke, Charles Rabkin, Scott Brown, Toni Choueiri, Elad Ziv, John Weinstein, Alexander Lazar
Journal: Cancer Commun (Lond)
Publication Date: 2019-11-26
Authors: Abraham Hakimi, Satish Tickoo, Nizar Tannir, Paul Russo, Yingbei Chen
Journal: Sci Rep
Publication Date: 2020-01-20
Lead Sponsor: Mundipharma Research Limited
Intervention / Treatment: DRUG: Tinostamustine 60mg/m2 over 30min, DRUG: Tinostamustine 80mg/m2 over 30min, DRUG: Tinostamustine 100mg/m2 over 30min, DRUG: Tinostamustine 60mg/m2 over 60min, DRUG: Tinostamustine 80mg/m2 over 60min, DRUG: Tinostamustine 100mg/m2 over 60min, DRUG: Tinostamustine 80mg/m2 over 80min
Lead Sponsor: HUYABIO International, LLC.
Intervention / Treatment: DRUG: HBI-8000 in combination with nivolumab
Lead Sponsor: X4 Pharmaceuticals
Intervention / Treatment: DRUG: axitinib, DRUG: X4P-001